/ IHRights#Iran: Hossein Amaninejad and Hamed Yavari were executed in Hamedan Central Prison on 11 June. Hossein was arrested… https://t.co/3lnMTwFH6z13 Jun

Reza Hosseini Executed in Hamedan

16 Nov 23
Reza Hosseini Executed in Hamedan

Iran Human Rights (IHRNGO); November 16, 2023: A drug death row prisoner named Seyed Reza Hosseini has been executed in Hamedan Central Prison.

According to information obtained by Iran Human Rights, a man was executed in Hamedan Central Prison on 13 November. His identity has been established as 45-year-old Seyed Reza Hosseini from Hamedan.

He was arrested for around five years ago sentenced to death for drug-related charges by the Revolutionary Court.

At the time of writing, his execution has not been reported by domestic media or officials in Iran.

Drug-related executions have continuously risen every year for the past three years. At least 305 people were executed for drug-related charges between 1 January-10 October 2023, a 69% increase compared to the same period in 2022, and the number of drug-related executions in 2023 were close to 20 times higher than 2020.

The number of drug executions dramatically dropped in 2018 following a 2017 Amendment to the Anti-Narcotics Laws. Consequently, drug executions ranged between 24-30 per annum between 2018-2020. The Amendment was reversed in practice in 2021 when executions increased ten-fold to 126 in 2021 and doubled again in 2022 with 256 drug-related executions. On 13 September 2023, IHRNGO reported a 94% rise in the number of drug-related executions in the year following the start of the “Woman, Life, Freedom” movement in September 2022.

In the first 10 months of 2023, IHRNGO recorded more than 600 executions, an unprecedented number in the last eight years. The majority of the executions were for drug-related charges which are also at their highest since 2015. On World Day Against the Death Penalty (10 October 2023), IHRNGO called on UN Member States to withdraw funding of UNODC projects on drug-trafficking in Iran, and to make all collaborations and funding contingent upon an immediate halt to all drug-related executions.